APLS logo

Apellis Pharmaceuticals (APLS) return on equity

annual ROE:

-93.55%+196.59%(+67.76%)
December 31, 2024

Summary

  • As of today (June 24, 2025), APLS annual return on equity is -93.55%, with the most recent change of +196.59% (+67.76%) on December 31, 2024.
  • During the last 3 years, APLS annual ROE has risen by +276.65% (+74.73%).
  • APLS annual ROE is now -173.14% below its all-time high of -34.25%, reached on December 31, 2017.

Performance

APLS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSprofitability metrics

quarterly ROE:

-96.34%-13.28%(-15.99%)
March 31, 2025

Summary

  • As of today (June 24, 2025), APLS quarterly return on equity is -96.34%, with the most recent change of -13.28% (-15.99%) on March 31, 2025.
  • Over the past year, APLS quarterly ROE has increased by +47.45% (+33.00%).
  • APLS quarterly ROE is now -168.66% below its all-time high of -35.86%, reached on June 30, 2015.

Performance

APLS quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

APLS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+67.8%+33.0%
3 y3 years+74.7%+85.9%
5 y5 years+89.5%+66.3%

APLS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+74.7%-16.0%+85.9%
5 y5-yearat high+89.5%-16.0%+94.0%
alltimeall time-173.1%+89.5%-168.7%+94.0%

APLS ROE History

DateAnnualQuarterly
Mar 2025
-
-96.34%(+16.0%)
Dec 2024
-93.55%(-67.8%)
-83.06%(-20.6%)
Sep 2024
-
-104.65%(-18.1%)
Jun 2024
-
-127.72%(-11.2%)
Mar 2024
-
-143.79%(-26.3%)
Dec 2023
-290.14%(-18.0%)
-195.18%(-5.5%)
Sep 2023
-
-206.55%(-1.3%)
Jun 2023
-
-209.36%(+2.2%)
Mar 2023
-
-204.92%(-7.5%)
Dec 2022
-353.93%(-4.4%)
-221.44%(-13.0%)
Sep 2022
-
-254.58%(-36.5%)
Jun 2022
-
-400.76%(-41.3%)
Mar 2022
-
-682.87%(-53.1%)
Dec 2021
-370.20%(+28.2%)
-1457.39%(-8.5%)
Sep 2021
-
-1593.25%(+213.3%)
Jun 2021
-
-508.46%(+110.0%)
Mar 2021
-
-242.18%(+40.7%)
Dec 2020
-288.86%
-172.12%(-49.4%)
Sep 2020
-
-339.93%(+20.1%)
Jun 2020
-
-283.06%(-1.0%)
DateAnnualQuarterly
Mar 2020
-
-285.84%(+30.8%)
Dec 2019
-890.20%(+1023.8%)
-218.57%(+63.7%)
Sep 2019
-
-133.48%(+27.4%)
Jun 2019
-
-104.81%(+36.0%)
Mar 2019
-
-77.09%(+8.2%)
Dec 2018
-79.21%(+131.3%)
-71.28%(+15.2%)
Sep 2018
-
-61.90%(-5.3%)
Jun 2018
-
-65.34%(-19.4%)
Mar 2018
-
-81.09%(-1.9%)
Dec 2017
-34.25%(-70.0%)
-82.65%(-58.0%)
Sep 2017
-
-196.85%(+34.4%)
Jun 2017
-
-146.48%(+52.3%)
Mar 2017
-
-96.16%(+65.4%)
Dec 2016
-114.00%(-14.3%)
-58.13%(+31.8%)
Sep 2016
-
-44.10%(-77.0%)
Dec 2015
-132.99%(+63.0%)
-191.88%(-24.8%)
Sep 2015
-
-255.00%(+611.1%)
Jun 2015
-
-35.86%(-8.1%)
Dec 2014
-81.58%(-6.9%)
-39.01%
Dec 2013
-87.60%
-

FAQ

  • What is Apellis Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual ROE year-on-year change?
  • What is Apellis Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly ROE year-on-year change?

What is Apellis Pharmaceuticals annual return on equity?

The current annual ROE of APLS is -93.55%

What is the all time high annual ROE for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual return on equity is -34.25%

What is Apellis Pharmaceuticals annual ROE year-on-year change?

Over the past year, APLS annual return on equity has changed by +196.59% (+67.76%)

What is Apellis Pharmaceuticals quarterly return on equity?

The current quarterly ROE of APLS is -96.34%

What is the all time high quarterly ROE for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly return on equity is -35.86%

What is Apellis Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, APLS quarterly return on equity has changed by +47.45% (+33.00%)
On this page